Ref.: BL-RE-143847Manufacturer ref.: EHSLAMF1X5 5 x 96 tests
€2,950.00 excl. VAT
ELISA SLAM sandwich kit (SLAMF1) (human): quantitative determination of Hu SLAM in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu SLAM.
Accession number
Q13291
Dose range
61.44 pg/ml to 15.000 pg/ml
Sensitivity of the dosage
60 pg/ml
Calibration range
60 pg/ml to 15.000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
ELISA SLAM sandwich kit (SLAMF1) (human): quantitative determination of Hu SLAM in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu SLAM.
ELISA SLAM sandwich kit (SLAMF1) (human): quantitative determination of Hu SLAM in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu SLAM.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
CD150 (SLAM, signaling lymphocyte activation molecule) belongs to the superfamily of genes of the immunoglobulins and is involved in T cell stimulation. SLAM is expressed constitutively on peripheral blood memory T cells, T cell clones, immature thymocytes and a proportion of B cells, and is rapidly induced on naïve T cells after activation. Activated B cells express membrane-bound shape, soluble form, and cytoplasmic isoforms of SLAM. It is suggested that SLAM-SLAM homophilic bonding signaling during interactions between B and B cells as well as between B and T cells improve the expansion and differentiation of activated B cells. Reports suggest that the extracellular domain of CD150 is the receptor of the measles virus and acts as a co-activating agent on T and B cells. Moreover, it is believed that CD150 interacts with SH2D1A and PTPN11 via its cytoplasmic domain. Mutations of the CD150 gene could be associated with X-related lymphoproliferative disease (XLP).
Sensitivity
Sensitivity of the dosage: 60 pg/ml.
Measurement range
Dose range: 61.44 pg/ml to 15.000 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Specificity
This pair of antibodies used by ELISA detects human SLAM. Other species not yet determined.